Shopping Cart
Remove All
Your shopping cart is currently empty
EOS006215 is a humanized monoclonal antibody inhibitor targeting TREM-2. It has the ability to reprogram TREM2+ macrophages, significantly hindering their tumor-promoting activities and overcoming drug resistance. In mouse models with orthotopic 4T1 triple-negative breast cancer, EOS006215 reduces metastatic burden. Additionally, it notably inhibits tumor growth in anti-PD-1 resistant mouse models. EOS006215 is applicable for studies on triple-negative breast cancer (TNBC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | EOS006215 is a humanized monoclonal antibody inhibitor targeting TREM-2. It has the ability to reprogram TREM2+ macrophages, significantly hindering their tumor-promoting activities and overcoming drug resistance. In mouse models with orthotopic 4T1 triple-negative breast cancer, EOS006215 reduces metastatic burden. Additionally, it notably inhibits tumor growth in anti-PD-1 resistant mouse models. EOS006215 is applicable for studies on triple-negative breast cancer (TNBC). |
| Synonyms | EOS-215 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.